Premium
P2‐020: Targeting Preclinical Stages of Alzheimer’s Disease: A Clinical Trial to Assess The Efficacy Of Curcumin Using Brain Biomarkers
Author(s) -
Goozee Kathryn G.,
Chatterjee Pratishtha,
Sohrabi Hamid R.,
Shen Kai Kai,
Ball Bethany,
Dave Preeti,
ManYan Candice,
Asih Prita Riana,
Taddei Kevin,
Martins Ralph N.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1224
Subject(s) - medicine , cohort , dementia , disease , curcumin , neuropsychology , positron emission tomography , magnetic resonance imaging , placebo , oncology , cognition , pathology , psychiatry , pharmacology , nuclear medicine , alternative medicine , radiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom